Acute graft-versus-host disease—biologic process, prevention, and therapy
When T cells from a bone marrow donor begin to attack the host within 3 months after
hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease
mainly affects the skin, liver, and gastrointestinal tract and is treated with
immunosuppressive drugs.
hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease
mainly affects the skin, liver, and gastrointestinal tract and is treated with
immunosuppressive drugs.
When T cells from a bone marrow donor begin to attack the host within 3 months after hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly affects the skin, liver, and gastrointestinal tract and is treated with immunosuppressive drugs.
The New England Journal Of Medicine